Coya Therapeutics, Inc.
COYA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $87 | $75 | $12 | $44 |
| - Cash | $38 | $33 | $6 | $4 |
| + Debt | $0 | $0 | $13 | $0 |
| Enterprise Value | $49 | $43 | $19 | $40 |
| Revenue | $4 | $6 | $0 | $0 |
| % Growth | -40.8% | – | – | – |
| Gross Profit | -$8 | $1 | -$4 | $0 |
| % Margin | -233.9% | 8.3% | – | – |
| EBITDA | -$17 | -$7 | -$9 | -$5 |
| % Margin | -483.9% | -122.2% | – | – |
| Net Income | -$15 | -$8 | -$12 | -$5 |
| % Margin | -418.7% | -133.1% | – | – |
| EPS Diluted | -0.98 | -0.79 | -1.231 | -0.74 |
| % Growth | -24.1% | 35.8% | -66.3% | – |
| Operating Cash Flow | -$10 | -$11 | -$7 | -$4 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$10 | -$11 | -$7 | -$4 |